RCKT (RCKT) Stock Price & Analysis
RCKT (RCKT) rose 1.85% to USD 3.86 as of September 8, 2026 at 06:20 UTC, according to Nexqual real-time market data.
RCKT last closed at USD 3.86; the session ranged USD 3.73–3.88 on volume of 888,541 shares. Market capitalization is —, with a 52-week range of USD 2.53–5.45 (NGM). Source: Nexqual, September 8, 2026 at 06:20 UTC.
Key Statistics (as of September 8, 2026 at 06:20 UTC)
| Price | USD 3.86 |
|---|---|
| Change | ▲ 1.85% (up) |
| Previous Close | USD 3.86 |
| Open | USD 3.86 |
| Day Range | USD 3.73 – 3.88 |
| 52-Week Range | USD 2.53 – 5.45 |
| Volume | 888,541 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (RCKT)
Nexqual's technical model rates RCKT "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 06:20 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 59.63 (neutral) |
| vs SMA50 | Above (USD 3.56) |
| MACD | 0.1 (positive) |
From RCKT's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ARVN | Arvinas, Inc. | USD 9.39 | ▼ 2.09% |
| RGNX | REGENXBIO Inc. | USD 8.94 | ▼ 6.88% |
| DNLI | Denali Therapeutics Inc. | USD 22.28 | ▼ 2.49% |
| REPL | Replimune Group, Inc. | USD 15.04 | ▼ 5.88% |
| KURA | Kura Oncology, Inc. | USD 13.25 | ▲ 1.07% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:20 UTC. This page is informational and not investment advice.